Versatile non-invasive application: Perfect for non-invasive mesotherapy, microneedling infusion, iontophoresis, ultrasound delivery, and electroporation
High treatment adherence among elderly patients, together with continuous innovation by domestic pharmaceutical companies and strong academic-industry collaboration, continues to strengthen GLP-1 receptor agonist utilization across the country
Clinical experience in treatment of Alzheimer's disease with Jiannao yizhi formula and routine western medicine
Safety outcomes included the occurrence of AKI, severe hypoglycemic events requiring medical attention, and discontinuation of GLP-1 RA therapy due to adverse effects, including pancreatitis and gallstones (cholelithiasis)
This is not a stimulant or a metabolism booster